Hongli Luo

Emerging nanomedicines for effective breast cancer immunotherapy

A. Bahreyni, Y. Mohamud, Hongli Luo, 2020, Journal of Nanobiotechnology.

The frequency and inter-relationship of PD-L1 expression and tumour mutational burden across multiple types of advanced solid tumours in China

Wei Zhu, Henghui Zhang, Xue Meng, 2020, Experimental Hematology & Oncology.

Comprehensive analysis of chemokines family and related regulatory ceRNA network in lung adenocarcinoma

F. Du, Zhangang Xiao, Xu Wu, 2022, Heliyon.

Massive PD-L1 and CD8 double positive TILs characterize an immunosuppressive microenvironment with high mutational burden in lung cancer

Jun Liu, Henghui Zhang, Yun Chen, 2021, Journal for ImmunoTherapy of Cancer.

The CD68+ macrophages to CD8+ T-cell ratio is associated with clinical outcomes in hepatitis B virus (HBV)-related hepatocellular carcinoma.

H. Zhang, Henghui Zhang, Shupeng Liu, 2020, HPB : the official journal of the International Hepato Pancreato Biliary Association.